These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 19629801

  • 1. Is depot medication safe in the setting of myopathy?
    Price JR, Bastiampillai T, Dhillon RS.
    Aust N Z J Psychiatry; 2009 Aug; 43(8):781-3. PubMed ID: 19629801
    [No Abstract] [Full Text] [Related]

  • 2. Leukopenia during therapy with risperidone long-acting injectable: two case reports.
    Uzun S, Kozumplik O, Jakovljević M, Folnegović-Smalc V.
    J Clin Psychopharmacol; 2008 Dec; 28(6):713-4. PubMed ID: 19011449
    [No Abstract] [Full Text] [Related]

  • 3. Hyperprolactinaemia on depot risperidone treated with aripiprazole.
    Anandarajan T, Tibrewal P, Dhillon R, Bastiampillai T.
    Aust N Z J Psychiatry; 2012 Aug; 46(8):792-3. PubMed ID: 22528973
    [No Abstract] [Full Text] [Related]

  • 4. Clinical guidelines: Dosing and switching strategies for long-acting risperidone.
    Marder SR, Conley R, Ereshefsky L, Kane JM, Turner MS.
    J Clin Psychiatry; 2003 Aug; 64 Suppl 16():41-6. PubMed ID: 14680418
    [No Abstract] [Full Text] [Related]

  • 5. Optimizing treatment with risperidone long-acting injections.
    Ceskova E.
    Acta Psychiatr Scand; 2012 Dec; 126(6):479-80. PubMed ID: 23106600
    [No Abstract] [Full Text] [Related]

  • 6. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J, Postma MJ, Bruggeman R, De Jong-Van Den Berg LT, Van Den Berg PB, Stolk RP, Burger H.
    J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
    [Abstract] [Full Text] [Related]

  • 7. Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication.
    Nesvåg R, Hendset M, Refsum H, Tanum L.
    Acta Psychiatr Scand; 2006 Jul; 114(1):21-6. PubMed ID: 16774657
    [Abstract] [Full Text] [Related]

  • 8. Treating Schizophrenia With 2 Long-Acting Injectable Antipsychotic Drugs: A Case Report.
    Wartelsteiner F, Hofer A.
    J Clin Psychopharmacol; 2015 Aug; 35(4):474-5. PubMed ID: 26075490
    [No Abstract] [Full Text] [Related]

  • 9. Inconsistency in risperidone long-acting injection steady-state plasma levels when switching from deltoid to gluteal administration.
    Elliott ES, Purvis TL, Nelson LA, Sommi RW.
    J Clin Pharmacol; 2010 Jun; 50(6):721-4. PubMed ID: 20067943
    [No Abstract] [Full Text] [Related]

  • 10. Risperidone vs. placebo for schizophrenia.
    Kripke C.
    Am Fam Physician; 2010 May 01; 81(9):1096. PubMed ID: 20433125
    [No Abstract] [Full Text] [Related]

  • 11. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
    Dursun S.
    J Psychopharmacol; 2005 Sep 01; 19(5 Suppl):3-4. PubMed ID: 16144780
    [No Abstract] [Full Text] [Related]

  • 12. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Int Clin Psychopharmacol; 2008 Nov 01; 23(6):325-31. PubMed ID: 18854720
    [Abstract] [Full Text] [Related]

  • 13. Long-acting risperidone-induced periorbital edema.
    Pelizza L.
    J Clin Psychopharmacol; 2008 Dec 01; 28(6):709-10. PubMed ID: 19011446
    [No Abstract] [Full Text] [Related]

  • 14. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.
    Lai YC, Chiou CC, Chen CH, Huang MC.
    J Clin Psychopharmacol; 2007 Oct 01; 27(5):523-4. PubMed ID: 17873693
    [No Abstract] [Full Text] [Related]

  • 15. Injectable sustained-release risperidone: recurrence of delirium and treatment failure.
    Prescrire Int; 2006 Oct 01; 15(85):183. PubMed ID: 17131515
    [No Abstract] [Full Text] [Related]

  • 16. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.
    Keith S.
    Expert Rev Neurother; 2009 Jan 01; 9(1):9-31. PubMed ID: 19102665
    [Abstract] [Full Text] [Related]

  • 17. Use of long-acting risperidone.
    Parker G.
    Psychiatr Serv; 2005 Jan 01; 56(1):105-6; author reply 106-7. PubMed ID: 15637203
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection.
    Bai YM, Chen TT, Lin WK, Chang WH, Wu B, Hung CH, Chou P, Chen JY.
    J Clin Psychopharmacol; 2007 Jun 01; 27(3):306-8. PubMed ID: 17502783
    [No Abstract] [Full Text] [Related]

  • 19. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    Mall GD, Hake L, Benjamin AB, Adityanjee A.
    J Clin Psychopharmacol; 2008 Oct 01; 28(5):572-3. PubMed ID: 18794658
    [No Abstract] [Full Text] [Related]

  • 20. Risperidone long-acting injection in practice - more questions than answers?
    Taylor D.
    Acta Psychiatr Scand; 2006 Jul 01; 114(1):1-2. PubMed ID: 16774654
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.